Percutaneous mitral valve repair: A new treatment for mitral regurgitation.
Mitral valve disease affects more than 4 million people in the United States. The gold standard of treatment in these patients is surgical repair or replacement of the valve with a prosthesis. The MitraClip (Abbott Vascular, Menlo Park, CA) is a new technology, which offers an alternative to open surgical repair or replacement via a minimally invasive route. We present an evidence-based clinical update that provides an overview of this technology as it relates to managing patients with significant mitral regurgitation. This review article is particularly useful to noninterventional cardiologists and interventional cardiologists who will be managing patients with this novel technology in increased volumes over the next decade but who do not perform this procedure.
Cavanagh Heart Center, Banner University Medical Center, Phoenix, AZ, United States.
Claire
C
Kelley
Cavanagh Heart Center, Banner University Medical Center, Phoenix, AZ, United States. Electronic address: mohamadlazkani@gmail.com.
Mohamad
M
Lazkani
Cavanagh Heart Center, Banner University Medical Center, Phoenix, AZ, United States.
Jennifer
J
Farah
Cavanagh Heart Center, Banner University Medical Center, Phoenix, AZ, United States.
Ashish
A
Pershad
D006328:Cardiac Catheterization / Q000379:methods*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008943:Mitral Valve / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000601:surgery*
Degenerative mitral regurgitation; Functional mitral regurgitation; MitraClip; Mitral valve repair; Valvulopathy